A Phase 3, Multi-Center, Open Label, Safety Study of RSD1235 in Subjects With Atrial Fibrillation
A Phase 3, Multi-Center, Open Label, Safety Study of RSD1235 in Subjects With Atrial Fibrillation
This study is designed to determine the safety of RSD1235 in patients with atrial fibrillation.
Inclusion Criteria:
Exclusion Criteria:
De Buenos Aires, Argentina
Tulunaw, CP4000, Argentina
Berea Durban, 4001, South Africa
Westdene Bloemfontein, 9301, South Africa